Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,027 public trials 2,025 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

NCT06182774

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Kelowna Kelowna, British Columbia, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 28 locations
View Trial Details
Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

NCT07280013

Conditions
Bites and Stings, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCLA Health, Jonsson Comprehensive Cancer Center Santa Monica, California, United States
  • University of Florida Gainesville, Florida, United States
View all 20 locations
View Trial Details
Recruiting

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

NCT05371808

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada
  • Lakeridge Health Oshawa Oshawa, Ontario, Canada
View Trial Details
Recruiting

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

NCT06289673

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Our Lady of the Lakes Regional Medical Center Baton Rouge, Louisiana, United States
  • Novant Health Presbyterian Hemby Children's Hospital Charlotte, North Carolina, United States
  • Saint Francis Children's Hospital Tulsa, Oklahoma, United States
View Trial Details
Recruiting

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

NCT04840602

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
View all 136 locations
View Trial Details

Related conditions